At the time of writing, Clover Health Investments Corp [CLOV] stock is trading at $3.05, up 5.54%. An important factor to consider is whether the stock is rising or falling in short-term value. The CLOV shares have gain 9.32% over the last week, with a monthly amount glided 0.99%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Clover Health Investments Corp [NASDAQ: CLOV] stock has seen the most recent analyst activity on December 17, 2024, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $6. Previously, UBS started tracking the stock with Neutral rating on October 07, 2024, and set its price target to $4. On February 02, 2022, upgrade upgraded it’s rating to Market Perform and revised its price target to $3 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $6 on February 02, 2022. SVB Leerink initiated its recommendation with a Mkt Perform and recommended $3 as its price target on January 19, 2022. In a note dated January 07, 2022, Credit Suisse downgraded an Underperform rating on this stock and revised its target price from $9 to $3.50.
For the past year, the stock price of Clover Health Investments Corp fluctuated between $1.27 and $4.87. Currently, Wall Street analysts expect the stock to reach $3.43 within the next 12 months. Clover Health Investments Corp [NASDAQ: CLOV] shares were valued at $3.05 at the most recent close of the market. An investor can expect a potential return of 12.46% based on the average CLOV price forecast.
Analyzing the CLOV fundamentals
According to Clover Health Investments Corp [NASDAQ:CLOV], the company’s sales were 1.49B for trailing twelve months, which represents an 33.45% jump. Gross Profit Margin for this corporation currently stands at 0.26% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.07 and Total Capital is -0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.92 points at the first support level, and at 2.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.23, and for the 2nd resistance point, it is at 3.41.
Ratios To Look Out For
It is important to note that Clover Health Investments Corp [NASDAQ:CLOV] has a current ratio of 1.54. Considering the valuation of this stock, the price to sales ratio is 1.04, the price to book ratio is 4.36.
Transactions by insiders
Recent insider trading involved Reynoso Jamie L., CEO, Medicare Advantage, that happened on Jul 03 ’25 when 19789.0 shares were sold. CEO, Medicare Advantage, Reynoso Jamie L. completed a deal on Jul 07 ’25 to sell 2012.0 shares. Meanwhile, Officer Wai Conrad bought 0.23 million shares on Jul 08 ’25.
